Invesco
ACER

Invesco’s Acer Therapeutics Inc ACER Stock Holding History

Invesco’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-35,873
Closed -$722K – 3860
2018
Q4 		$722K Sell
35,873
-4,509
-11% -$104K ﹤0.01% 3130
2018
Q3 		$1.25M Buy
+40,382
New +$1.08M ﹤0.01% 3031

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Invesco's ACER Position: Q1 2019 in Review

Invesco sold out of Acer Therapeutics Inc (ACER) in Q1 2019, closing a stake of 35,873 shares — an estimated $722K sold.

Invesco first reported a position in ACER in Q3 2018 and held it in 2 quarters. The position peaked at $1.25M in Q3 2018. 34 funds tracked by Wall St. Rank hold ACER as of Q1 2019.

  • Invesco reported no remaining Acer Therapeutics Inc position as of Q1 2019 after selling out during the quarter.
  • Invesco sold 35,873 Acer Therapeutics Inc shares in Q1 2019, an estimated $722K.
  • Invesco first reported a position in Acer Therapeutics Inc in Q3 2018 and held it in 2 quarters.
  • Invesco's Acer Therapeutics Inc position peaked at $1.25M in Q3 2018.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.